Range Low Price High Price Comment
30 days $1.08 $1.08 Friday, 27th May 2022 CGIX stock ended at $1.08. During the day the stock fluctuated 0% from a day low at $1.08 to a day high of $1.08.
90 days $1.07 $1.18
52 weeks $0.82 $4.24

Historical Cancer Genetics prices

Date Open High Low Close Volume
Feb 29, 2016 $2.13 $2.25 $2.13 $2.20 62 800
Feb 26, 2016 $2.13 $2.18 $2.06 $2.11 65 800
Feb 25, 2016 $2.13 $2.14 $2.01 $2.09 92 000
Feb 24, 2016 $2.20 $2.23 $2.07 $2.10 165 100
Feb 23, 2016 $2.31 $2.32 $2.20 $2.22 28 300
Feb 22, 2016 $2.23 $2.37 $2.20 $2.23 62 500
Feb 19, 2016 $2.25 $2.25 $2.07 $2.21 65 900
Feb 18, 2016 $2.20 $2.33 $2.10 $2.23 86 900
Feb 17, 2016 $2.12 $2.22 $2.01 $2.17 153 300
Feb 16, 2016 $2.32 $2.32 $2.02 $2.10 147 800
Feb 12, 2016 $2.12 $2.28 $2.05 $2.27 41 200
Feb 11, 2016 $2.17 $2.22 $2.05 $2.07 49 200
Feb 10, 2016 $2.11 $2.30 $2.07 $2.18 72 400
Feb 09, 2016 $2.21 $2.26 $2.06 $2.07 76 200
Feb 08, 2016 $2.46 $2.48 $2.20 $2.29 91 800
Feb 05, 2016 $2.51 $2.77 $2.37 $2.49 76 100
Feb 04, 2016 $2.50 $2.63 $2.45 $2.54 31 200
Feb 03, 2016 $2.55 $2.59 $2.36 $2.52 77 500
Feb 02, 2016 $2.76 $2.85 $2.48 $2.50 56 700
Feb 01, 2016 $2.59 $2.81 $2.56 $2.79 52 700
Jan 29, 2016 $2.49 $2.65 $2.41 $2.61 42 100
Jan 28, 2016 $2.58 $2.73 $2.43 $2.46 42 300
Jan 27, 2016 $2.63 $2.67 $2.51 $2.52 32 000
Jan 26, 2016 $2.57 $2.72 $2.42 $2.64 82 600
Jan 25, 2016 $2.48 $2.57 $2.44 $2.53 62 600
Click to get the best stock tips daily for free!

About Cancer Genetics

Cancer Genetics Cancer Genetics, Inc. develops, commercializes, and provides molecular and biomarker-based tests and services in the United States, India, and China. Its tests enable physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor, and inform cancer treatment; and enable biopharmaceutical companies involved in oncology trials to select candidate populations and reduce adverse drug... CGIX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT